3 Peaks Charity Event a Great Success!
Three intrepid Interceptors joined Robert Mitchell-Thain of the PBC Foundation to climb the three highest mountains in Britain in aid of the charity. Following our attendance at the British Association …
Three Peaks for International PBC Day
[otw_shortcode_info_box border_type=”bordered” border_color_class=”otw-green-border” border_style=”bordered” icon_type=”general foundicon-idea” icon_color_class=”otw-black-text”]This event is now complete. Please read the update article on this event here.[/otw_shortcode_info_box] On Sunday 11th September it is the World PBC day, and …
Research Participants Needed – Have Your Say
Researchers from University of Birmingham are looking for patients to take part in a study looking at the patient experience of living with Primary Biliary Cholangitis (formerly known as Primary Biliary …
POISE Study (PBC OCA International Study of Efficacy) results published in New England Journal of Medicine
New England Journal of Medicine (NEJM) has published the POISE Study (PBC OCA International Study of Efficacy) manuscript in this week’s (W/C 15/08/2016) edition of the journal. Intercept received FDA …
Re-consent of the UK-PBC Research Cohort
As part of the re-consenting process, the revised Participant Information Sheet (PIS) and Informed Consent Form (ICF) were sent to each and every participant at the beginning of April 2016. We …
CymaBay Therapeutics closes Its Phase 2 Study of MBX-8025 in Patients With Primary Biliary Cholangitis (PBC) early
After review of safety and efficacy data, CymaBay Therapeutics stopped their Phase 2 study of MBX-8025 in Patients With Primary Biliary Cholangitis (PBC) early, due to data clearly demonstrating proof-of-concept …
UK-PBC Spring 2016 Newsletter (IS003)
The UK-PBC Winter Spring, with many positive updates on the project. Download and read now. DOWNLOADS UK-PBC Newsletter Spring 2016 (IS003) PDF 1Mb
The British Society of Gastroenterology/UK-PBC Primary Biliary Cholangitis (formerly known as Primary Biliary Cirrhosis) Treatment and Management Guidelines (For Consultation Only)
[otw_shortcode_info_box border_type=”bordered” border_color_class=”otw-green-border” border_style=”bordered” icon_type=”general foundicon-idea” icon_color_class=”otw-black-text”]Review window closed on 31st May 2016. Thank you to everyone who provided feedback..[/otw_shortcode_info_box] The British Society of Gastroenterology/UK-PBC Primary Biliary Cholangitis (formerly known …
FDA Support for Obeticholic Acid (OCA)
UK-PBC team helps new PBC drug to the point of licensing. UK-PBC investigators have been heavily involved in the FDA approval process for Obeticholic Acid, a novel drug for …
UK-PBC Smartphone App gains media attention and award
The UK-PBC Risk Score iPhone app was recently featured in a visit by George Freeman MP, Minisiter for Life Sciences, to Newcastle University. The visit was captured in full by …
